Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: Comparison between heparin-sensitive and heparin-resistant cultures

Journal of Cellular Physiology

Volumn 167, Issue 1, 1996, Pages 8-21

  Bârzu, Tereza ^a   Pascal, Marc ^a   Maman, Michel ^a   Roque, Claude ^a   Lafont, Frank ^b   Rousselet, Annie ^b,c  

^a SANOFI   (France)

^b CNRS   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CONCANAVALIN A; FIBRONECTIN; FLUORESCEIN; HEPARIN DERIVATIVE; LAMININ; SCLEROPROTEIN; SR 80037A; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BINDING; DRUG UPTAKE; ELECTRON MICROSCOPY; ENDOCYTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DIVISION; CELLS, CULTURED; DRUG RESISTANCE; ENDOCYTOSIS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HEPARIN; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0030005773     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199604)167:1<8::AID-JCP2>3.0.CO;2-T     Document Type: Article

References (42)

1. Au, Y.P.T., Kenagy, R.D., and Clowes, A.W. (1992a) Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J. Biol. Chem., 267:3438-3444.
2. Au, Y.P.T., Montgomery, K.F., and Clowes, A.W. (1992b) Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells. Circ. Res., 70:1062-1069.
3. Au, Y.P.T., Kenagy, R.D., Clowes, M.M., and Clowes, A.W. (1993) Mechanism of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis, 23(suppl 1):177-182.
4. Au, Y.P.T., Dubrowolska, G., Morris, D.R., and Clowes, A.W. (1994) Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. Circ. Res., 75:15-22.
5. Bârzu, T., Desmoulière, A., Herbert, J.M., Level, M., Herault, J.P., Petitou, M., Lormeau, J.C., Gabbiani, G., and Pascal, M. (1992) O-acylated heparin derivatives with low anticoagulant activity decrease proliferation and increase α-smooth muscle actin expression in cultured arterial smooth muscle cells. Eur. J. Pharmacol., 219:225-233.
6. Bârzu, T., Herbert, J.M., Desmoulière, A., Carayon, P., and Pascal, M. (1994) Characterization of rat smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment. J. Cell. Physiol., 160:239-248.
7. Bârzu, T., van Rijn, J.L.M.L., Tobelem, G., and Caen, J.P. (1987) Heparin degradation in the endothelial cells. Thromb. Res., 47:607-609.
8. Bouteille, M. (1976) The "LIGOP" method for routine ultrastructural autoradiography. A combination of single grid coating gold latensification and Phenidon development. J. Microsc. Biol. Cell. 27:121-128.
9. Busch, S.J., Martin, G.A., Barnhart, R.L., Masayuki, M., Cardin, A.D., and Jackson, R.L. (1992) Trans-repressor activity of nuclear glycosaminoglycans on fos and jun/AP-1 oncoprotein mediated transcription. J Cell Biol., 116:31-42.
10. Campbell, J.H., Campbell, J.R. (1987) Methods of growing vascular smooth muscle cells. In: Vascular Smooth Muscle in Culture. J.H. Campbell, J.R. Campbell, eds. CRC Press, Inc., Boca Raton, Florida, pp. 15-22.
11. Castellot, J.J., Jr., Wong, K., Herman, B., Hoover, R.L., Albertini, D.F., Wright, T.C., Caleb, B.L., and Karnovsky, M.J. (1985) Binding and internalization of heparin by vascular smooth muscle cells. J. Cell. Physiol., 124:13-20.
12. Castellot, J.J., Jr., Pukac, L.A., Caleb, B., Wright, T.C., Jr., and Karnovsky, M.J. (1989) Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J. Cell Biol., 109:3147-3155.
13. Desmoulière, A., and Gabbiani, G. (1992) The role of arterial smooth muscle cells in the pathogenesis of atherosclerosis. Cerebrovasc. Dis., 2:63-71.
14. Desmoulière, A., Rubbia-Brandt, L., and Gabbiani, G. (1991) Modulation of actin isoform expression in cultured arterial smooth muscle cells by heparin and culture conditions. Arterioscler. Thromb., 11:244-253.
15. Fager, G., Camejo, G., and Bondjers, G. (1992a) Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of platelet-derived growth factor by heparin. In Vitro Cell. Dev. Biol. 28A:168-175.
16. Fager, G., Camejo, G., Olsson, U., Östergren-Lundén, G., and Bondjers, G. (1992b) Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. II The platelet-derived growth factor A-chain contains a sequence that specifically binds heparin. In Vitro Cell. Dev. Biol 28A:176-180.
17. Fedarko, N.S., and Conrad H.E. (1986) A unic heparan sulfate proteoglycan in the nuclei of hepatocytes: Structural changes with the growth state of the cells. J. Cell Biol., 102:587-599.
18. Fritze, L.M.S., Reilly, C.F., and Rosenberg, R.D. (1985) An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J. Cell Biol. 100:1041-1049.
19. Goldstein, J.C., Brown, M.S., Anderson, R.J.W., Russel, D.W., and Scheinder, W.J. (1985) Receptor mediated endocytosis. Concept emerging from LDL receptor system. Annu. Rev. Cell Biol., 1:1-39.
20. Grainger, D.J., Witchell, C.M., Watson, J.V., Metcalfe, J.C., and Weissberg, P.L. (1993) Heparin decreases the rate of the proliferation of rat smooth muscle cells by releasing transforming growth factor β-like activity from serum. Cardiovasc. Res., 27:2238-2247.
21. Hamati, H.F., Britton, E.L., and Carey, D.J. (1989) Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture. J. Cell Biol., 108:2495-2005.
22. Ishihara, M., Fedarko, N.S., and Conrad, H.E. (1986) Transport of heparan sulfate into the nuclei of hepatocytes. J. Biol. Chem., 261:13575-13580.
23. Kenagy, R.D., Nikkari, S.T., Welgus, H.G., and Clowes, A.W. (1994) Heparin inhibits the induction of three matrix metalloproteases (stromelysin, 92-kD gelatinases and collagenase) in primate arterial smooth muscle cells. J. Clin. Invest., 93:1987-1993.
24. Lafont, F., Prochiantz, A., Valenza, C., Petitou, M., Pascal, M., Rouget, M., and Rousselet, A. (1994) Defined glycosaminoglycan motifs have opposite effects on neuronal polarity in vitro. Dev. Biol., 165:453-468.
25. Liau, G., and Chan, L.M. (1989) Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J. Biol. Chem., 264:10315-10320.
26. Lindner, V., Olson, N.E., Clowes, A.W., and Reidy, M.A. (1992) Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J. Clin. Invest., 90:2044-2049.
27. Liss, H., and Sharon, N. (1986) Lectins as molecules and tools. Annu. Rev. Biochem., 55:35-67.
28. Majak, R.A., Cook, S.C., and Bornstein, P. (1985) Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix of smooth muscle cells. J. Cell Biol., 101:1059-1070.
29. McCaffrey, T.A., Falcone, D.J., Brayton, C.F., Agarwal, L.A., Welt, F.G., and Weksler, B.B. (1989) Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin complex. J. Cell Biol., 109:441-448.
30. Okhuma, S., and Poole, B. (1978) Fluorescent probe measurement of the intralysosomal pH in the living cells and the perturbation of pH by various agents. J. Cell Biol., 75:3327-3331.
31. Ottlinger, M.E., Pukac, L.A., and Karnovsky, M.J. (1993) Heparin inhibits mitogen-activated protein-kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem., 268:19173-19176.
32. Petitou, M., Coudert, C., Level, M., Lormeau, J.C., Zuber, M., Simenel, C., Fournier, J.P., and Choay, J. (1992) Selectively O-acylated glycosaminoglycan derivatives. Carbohydr. Res., 236:107-119.
33. Pukac, L.A , Castellot, J.J., Jr., Wright, T.C., Jr., Caleb, B.L., and Karnovsky, M.J. (1990) Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul., 1:435-443.
34. Pukac, L.A., Hirsch, G.M., Lormeau, J.C., Petitou, M., Choay, J., and Karnowsky, M.J. (1991) Antiproliferative activity of novel, non-anticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo. Am. J. Pathol., 139:1501-1509.
35. Pukac, L.A., Ottlinger, M.E., and Karnovsky, M.J. (1992) Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J. Biol. Chem., 267:3707-3711.
36. Reilly, C.F., Fritze, L.M.S., and Rosenberg, R.D. (1986) Heparin inhibition of smooth muscle cell proliferation: A cellular site of action. J. Cell. Physiol., 129:11-19.
37. Schwartz, S.M., and Liaw, L. (1993) Growth control and morphogenesis in the development and pathology of arteries. J. Cardiovasc Pharmacol., 21:S31-S49.
38. Sing, J.P., Wiernicki, T.R., and Gupta, S K. (1993) Role of serine/ threonine kinase casein kinase-II in the vascular smooth muscle cell proliferation and inhibition by heparin. Drug Dev. Res., 29:129-136.
39. Tan, E.M.L., Dodge, G.R., Sorger, T., Kovalsky, I , Unger, G.A., Yang, L , Levine, E., and Iozzo, R.V. (1991) Modulation of extracellular matrix gene expression by heparin and endothelial cell growth factor in human smooth muscle cells. Lab. Invest. 64:474-482.
40. Watanabe, J., Muranishi, H., Haba, M., and Yuasa, H. (1993) Uptake of (FITC)-fractionated heparin by rat parenchymal hepatocytes in primary culture. Biol. Pharm. Bull., 16:939-941.
41. Weissberg, L.P., Grainger, D.J., Shanahan, C.M., and Metcalfe, J.C. (1993) Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. Cardiovasc. Res., 27:1191-1198.
42. Wright, T.C., Pukac, L.A., Castellot, J.J., Karnovsky, M.J., Levine, R.A., Kim-Park, H.-Y., and Campisi, J. (1989) Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc. Natl. Acad. Sci. USA, 86:3199-3203.